Process for the preparation of quinazolinones
US6175009A · kind A · utility
6Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 1999 |
| Grant date | Jan 16, 2001 |
| Priority date | — |
| Expiry date | Nov 18, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/80
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates generally to an asymmetric synthesis of 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones, and intermediates thereof. The target compounds are useful for the treatment of human immunodeficiency virus (HIV) as an inhibitor of reverse transcriptase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.